Paper Details

  1. Home
  2. Paper Details

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.

Author: HarrowerA D

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review of three clinical trials compared the efficacy of different sulfonylureas in treating type II diabetes. Gliclazide demonstrated superior efficacy and a lower secondary failure rate compared to other sulfonylureas, including glibenclamide, glipizide, and gliquidone. Gliclazide also had a lower incidence of hypoglycemia.
Paper Details　
Original Abstract of the Article :
The data from three clinical trials are presented, comparing the efficacy of different sulfonylureas in the treatment of type II diabetes. In a multicenter study, gliclazide improved control in 49% of patients who had failed on other drugs. When five groups of type II diabetic patients were treated ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/1056-8727(94)90044-2

データ提供：米国国立医学図書館（NLM）

Sulfonylureas: A Comparative Study of Efficacy and Safety

The management of [type II diabetes] involves finding the right medication to manage [blood sugar] levels. This study compares the efficacy and safety of different types of [sulfonylureas], a class of drugs used for [diabetes management]. It's like exploring a collection of different oases, each with its own unique properties and potential benefits.

Gliclazide Emerges as a Potential Leader in Sulfonylurea Therapy

The study found that [gliclazide] consistently outperformed other [sulfonylureas] in terms of [efficacy], with a lower [secondary failure rate] and fewer side effects. It's like finding an oasis that offers both refreshing water and a safe haven from the harsh desert environment. This study suggests that [gliclazide] may be a valuable treatment option for [type II diabetes].

Managing Type II Diabetes: A Desert Journey with a Map

This study provides valuable insights into the management of [type II diabetes], highlighting the importance of choosing the right medication and dosage. It's like navigating a desert, having a map to guide your way and ensure a safe and successful journey. It's a reminder that even in the face of a chronic condition, there are solutions and tools to help you manage your health and lead a fulfilling life.

Dr. Camel's Conclusion

This study offers a valuable comparison of different [sulfonylureas] and highlights the potential benefits of [gliclazide] in managing [type II diabetes]. It's a reminder that the desert of [diabetes management] is vast and diverse, but with the right knowledge and guidance, we can find the most effective solutions to improve patient well-being. Let's continue to explore new therapies and find the best paths to better health for those affected by this condition.

Date :
  1. Date Completed 1995-03-02
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

7833494

DOI: Digital Object Identifier

10.1016/1056-8727(94)90044-2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.